Is Nu Skin Stock a Good Investment?
Nu Skin Investment Advice | NUS |
- Examine Nu Skin's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Nu Skin's leadership team and their track record. Good management can help Nu Skin navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Personal Care Products space and any emerging trends that could impact Nu Skin's business and its evolving consumer preferences.
- Compare Nu Skin's performance and market position to its competitors. Analyze how Nu Skin is positioned in terms of product offerings, innovation, and market share.
- Check if Nu Skin pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Nu Skin's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Nu Skin Enterprises stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Nu Skin Enterprises is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Insignificant | Details | |
Volatility | Moderately volatile | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Moves slightly opposite to the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Not Available | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Examine Nu Skin Stock
Researching Nu Skin's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 78.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.59. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Nu Skin Enterprises has Price/Earnings To Growth (PEG) ratio of 2.35. The entity recorded a loss per share of 2.95. The firm last dividend was issued on the 24th of February 2025.
To determine if Nu Skin is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Nu Skin's research are outlined below:
| Nu Skin Enterprises had very high historical volatility over the last 90 days | |
| The company reported the last year's revenue of 1.73 B. Reported Net Loss for the year was (146.59 M) with profit before taxes, overhead, and interest of 1.22 B. | |
| Over 78.0% of the company shares are owned by institutional investors |
Nu Skin uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Nu Skin Enterprises. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Nu Skin's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 14th of February 2024 Upcoming Quarterly Report | View | |
| 1st of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 14th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Nu Skin's market capitalization trends
The company currently falls under 'Small-Cap' category with a total capitalization of 383.36 M.Nu Skin's profitablity analysis
The company has Net Profit Margin of (0.08) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of 0.07 %, which entails that for every 100 dollars of revenue, it generated $0.07 of operating income.Determining Nu Skin's profitability involves analyzing its financial statements and using various financial metrics to determine if Nu Skin is a good buy. For example, gross profit margin measures Nu Skin's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Nu Skin's profitability and make more informed investment decisions.
Please note, the imprecision that can be found in Nu Skin's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Nu Skin Enterprises. Check Nu Skin's Beneish M Score to see the likelihood of Nu Skin's management manipulating its earnings.
Basic technical analysis of NUS Stock
As of the 24th of March, Nu Skin owns the Standard Deviation of 4.43, mean deviation of 2.96, and Market Risk Adjusted Performance of (0.34). In relation to fundamental indicators, the technical analysis model lets you check practical technical drivers of Nu Skin Enterprises, as well as the relationship between them. Please verify Nu Skin Enterprises market risk adjusted performance, variance, as well as the relationship between the Variance and potential upside to decide if Nu Skin Enterprises is priced correctly, providing market reflects its prevailing price of 7.71 per share. Given that Nu Skin Enterprises has jensen alpha of 0.2279, we recommend you to check Nu Skin's latest market performance to make sure the company can sustain itself at some point in the future.Nu Skin's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Nu Skin insiders, such as employees or executives, is commonly permitted as long as it does not rely on Nu Skin's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Nu Skin insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Nu Skin's Outstanding Corporate Bonds
Nu Skin issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Nu Skin Enterprises uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most NUS bonds can be classified according to their maturity, which is the date when Nu Skin Enterprises has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Understand Nu Skin's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Nu Skin's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.0618 | |||
| Market Risk Adjusted Performance | (0.34) | |||
| Mean Deviation | 2.96 | |||
| Semi Deviation | 3.14 | |||
| Downside Deviation | 3.46 | |||
| Coefficient Of Variation | 1676.62 | |||
| Standard Deviation | 4.43 | |||
| Variance | 19.6 | |||
| Information Ratio | 0.0656 | |||
| Jensen Alpha | 0.2279 | |||
| Total Risk Alpha | 0.4331 | |||
| Sortino Ratio | 0.084 | |||
| Treynor Ratio | (0.35) | |||
| Maximum Drawdown | 22.79 | |||
| Value At Risk | (5.05) | |||
| Potential Upside | 7.77 | |||
| Downside Variance | 11.97 | |||
| Semi Variance | 9.88 | |||
| Expected Short fall | (3.48) | |||
| Skewness | 1.65 | |||
| Kurtosis | 4.67 |
| Risk Adjusted Performance | 0.0618 | |||
| Market Risk Adjusted Performance | (0.34) | |||
| Mean Deviation | 2.96 | |||
| Semi Deviation | 3.14 | |||
| Downside Deviation | 3.46 | |||
| Coefficient Of Variation | 1676.62 | |||
| Standard Deviation | 4.43 | |||
| Variance | 19.6 | |||
| Information Ratio | 0.0656 | |||
| Jensen Alpha | 0.2279 | |||
| Total Risk Alpha | 0.4331 | |||
| Sortino Ratio | 0.084 | |||
| Treynor Ratio | (0.35) | |||
| Maximum Drawdown | 22.79 | |||
| Value At Risk | (5.05) | |||
| Potential Upside | 7.77 | |||
| Downside Variance | 11.97 | |||
| Semi Variance | 9.88 | |||
| Expected Short fall | (3.48) | |||
| Skewness | 1.65 | |||
| Kurtosis | 4.67 |
Consider Nu Skin's intraday indicators
Nu Skin intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Nu Skin stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Nu Skin time-series forecasting models is one of many Nu Skin's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Nu Skin's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
NUS Stock media impact
Far too much social signal, news, headlines, and media speculation about Nu Skin that are available to investors today. That information is available publicly through NUS media outlets and privately through word of mouth or via NUS internal channels. However, regardless of the origin, that massive amount of NUS data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Nu Skin news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Nu Skin relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Nu Skin's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Nu Skin alpha.
Nu Skin Corporate Directors
| Scott Pond | Director - Investor Relations | Profile | |
| Thomas Pisano | Independent Director | Profile | |
| Zheqing Shen | Independent Director | Profile | |
| Daniel Campbell | Lead Independent Director | Profile |
Additional Tools for NUS Stock Analysis
When running Nu Skin's price analysis, check to measure Nu Skin's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nu Skin is operating at the current time. Most of Nu Skin's value examination focuses on studying past and present price action to predict the probability of Nu Skin's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nu Skin's price. Additionally, you may evaluate how the addition of Nu Skin to your portfolios can decrease your overall portfolio volatility.